Jim Cramer on Structure Therapeutics: “I Don’t Want to Touch It”

7 months ago 46

Skip to navigation Skip to main contented Skip to close file

Syeda Seirut Javed

Fri, January 16, 2026 astatine 11:13 AM CST 1 min read

Structure Therapeutics Inc. (NASDAQ:GPCR) is 1 of the stocks connected Jim Cramer’s radar recently. When a caller inquired astir the stock, Cramer commented:

“Oh, okay, truthful this is a, they person a woody with Roche, and therefore, I deliberation it’s a morganatic idea, but, boy, the banal afloat reflects that deal. I don’t privation to interaction it. Lilly is inactive the golden standard.”

Structure Therapeutics Inc. (NASDAQ:GPCR) develops oral small-molecule drugs to dainty chronic conditions similar obesity and pulmonary fibrosis.

While we admit the imaginable of GPCR arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.